DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

Oncology Homepage

FDA clears IsoRay's and GT's cesium-131 based brachytherapy Performed during surgery to remove brain tumor, reduces follow-ups

Onkos Surgical and Insight Medical partner to bring augmented reality to tumor surgery Could this become the new standard of care?

Andrew J. Evans and Erik P. Sulman NYU Langone Health hires nationally renowned radiation oncologists

Combined radionuclide therapy and immunotherapy shows promise New research unveiled at SNMMI meeting

RaySearch releases RayStation 8A Offers greater support for radiation, proton and carbon ion therapies

Radiotherapy IT company CruxQS acquires RDS Will expand footprint for FlowBoard workflow management system

New model boosts flow efficiency of particle accelerators May lead to smaller accelerators, easier to operate at reduced costs

Why are breast cancer survivors foregoing recommended screening? Study finds poor adherence to annual mammogram guidelines

Is low cost Proton-to-Carbon Heavy Ion radiotherapy coming soon? Best Particle Therapy plans to bring smaller footprint system to market in two to three years

Researchers develop AI approach for high-risk clinical tumor volumes Assisting low- and middle-income countries that lack contouring expertise

A cancer center in South Wales
has administered proton therapy to
the first patient in the U.K.

Proton therapy arrives in the UK

by John R. Fischer , Staff Reporter
The Rutherford Cancer Centre South Wales has delivered the first bout of proton therapy treatment in the U.K. to a cancer patient.

The arrival of the high-energy cancer-fighting method, proven to target tumors more precisely and produce fewer side effects compared to conventional radiotherapy, provides Brits with the option to seek out the treatment domestically rather than travel abroad for it.

Story Continues Below Advertisement

Breast Health Solutions

Innovative AI software solutions built on deep learning for breast tomosynthesis, breast density and 2D mammography. Learn more>



“After many years being behind the game, the U.K. can now deliver a transformational change for cancer patients over the next five years with Rutherford Cancer Centres,” Professor Karol Sikora, chief medical officer of the center’s parent company, Proton Partners International (PPI), told HCB News. “Proton Partners International's aim is to have a Rutherford Cancer Centre within 90 minutes of 75 percent of the U.K. population by 2021. There is a growing demand for proton beam therapy, and we as a country need to be fully equipped to meet that demand."

More than 150,000 U.K. cancer patients undergo radiation therapy annually. PPI argues that ten percent who receive radical radiotherapy would benefit more from PT, ushering in a need for at least 15 more such facilities.

The Welsh-based enterprise itself plans to open eight more PT cancer centers across the U.K., eliminating long-distance travel for patients to countries such as the U.S. and Switzerland, where costs for such treatments add up to around £114,000 (over $140,000).

The Rutherford Cancer Centre South Wales utilizes a single-room Proteus One proton beam therapy system, designed by Ion Beam Applications (IBA) Group and approved for use there in February.

The system, installed in May 2017, is more compact than large multi-room systems, and is equipped with pencil beam scanning, enabling precise targeting of tumors while minimizing exposure to healthy tissues.

IBA plans to supply and provide maintenance for Proteus One systems at PPI’s eight other centers in development, agreeing to do so for the last three in March.

PPI is also engaged in a two-year collaborative research project with the University of Liverpool to develop a measurement system to enhance proton beam therapy technology, and has joined The College of Radiographers’ Industry Partnership Scheme to fund future research and educational projects.

“At least with proton beam therapy now underway in Wales, we now have a road map that is taking us from the B class road to the motorway and patients will benefit from leaving the scenic route behind,” said Sikora. “We are still far behind Europe and the USA but what is hugely encouraging is that we as a country will no longer have to send patients to the United States or Europe for proton beam therapy."

The initiation of PT therapy in the U.K. follows that of the Netherlands which treated its own first patient last month, and the opening of the first PT therapy facility in Russia whose first patient has already completed treatment.

The Rutherford Cancer Centres treats self-paying patients and those with health insurance. Treatment is also available to patients referred by an NHS Trust.

Oncology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED